Ubs Group Ag Inventiva S.A. Transaction History
Ubs Group Ag
- $527 Billion
- Q4 2024
A detailed history of Ubs Group Ag transactions in Inventiva S.A. stock. As of the latest transaction made, Ubs Group Ag holds 609,245 shares of IVA stock, worth $1.73 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
609,245Holding current value
$1.73 Million% of portfolio
0.0%Shares
13 transactions
Others Institutions Holding IVA
# of Institutions
7Shares Held
5.45MCall Options Held
0Put Options Held
0-
Yiheng Capital Management, L.P. San Francisco, CA2.64MShares$7.51 Million0.23% of portfolio
-
Nea Management Company, LLC Timonium, MD1.46MShares$4.15 Million0.22% of portfolio
-
Bvf Inc San Francisco, CA686KShares$1.95 Million0.05% of portfolio
-
Commonwealth Equity Services, LLC42KShares$119,2770.0% of portfolio
-
Covestor LTD Boston, MA402Shares$1,1410.0% of portfolio
About Inventiva S.A.
- Ticker IVA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,134,200
- Market Cap $120M
- Description
- Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company als...